Skip to Content

Bupivacaine Pregnancy and Breastfeeding Warnings

Bupivacaine is also known as: Marcaine, Marcaine HCl, Marcaine Spinal, Sensorcaine, Sensorcaine-MPF, Sensorcaine-MPF Spinal

Bupivacaine Pregnancy Warnings

Bupivacaine has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryolethality at doses exceeding the maximum recommended daily human dose and developmental toxicity when administered subcutaneously at clinically relevant doses. There are no controlled data in human pregnancy. Bupivacaine in only recommended for use during pregnancy when benefit outweighs risk. This recommendation does not exclude the use of bupivacaine at term for obstetrical anesthesia or analgesia.

Bupivacaine with a high protein binding capacity has a low fetal/maternal ratio of 0.2 to 0.4. Local anesthetics rapidly cross the placenta. Adverse reactions in the mother and/or neonate are dependent upon the route of administration, procedure, and amount of drug used. Toxic reactions may include alterations in the central nervous system, peripheral vascular tone, and cardiac function. Maternal hypotension during obstetrical procedures has occurred during regional anesthesia. Elevating the patient's legs and positioning on the left side will help to prevent this effect. The fetal heart rate should be continuously monitored.

See references

Bupivacaine Breastfeeding Warnings

Bupivacaine is excreted into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or not administer the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Marcaine HCl (bupivacaine)." Hospira Inc, Lake Forest, IL.
  2. "Product Information. Sensorcaine-MPF (bupivacaine)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.

References for breastfeeding information

  1. "Product Information. Sensorcaine-MPF (bupivacaine)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.
  2. "Product Information. Marcaine HCl (bupivacaine)." Hospira Inc, Lake Forest, IL.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.